As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

Pfizer CEO Albert Bourla has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his ...

CEO Albert Bourla has reportedly said that the company has made no commitments during its meeting with the Trump ...

Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how reduced ...

STORY: Pfizer CEO Albert Bourla said Monday that he and other drug companies met with the Trump administration to discuss ...

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.

When a novel coronavirus struck in early 2020, Pfizer’sPFE1.22%increase; green up pointing triangle chief executive, Dr. Albert Bourla, saw an opportunity to help save the world. He pushed the ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...